NorthWest Biotherapeutics Inc (NWBO)

[Rkmatters]

I like honesty. I like integrity. I look for these things in management. The Ph III trial prior to the change was 240 patients plus up to 72 psPD. All press releases used the 312 patient count number in their "about us". That count included psPDs. Nothing wrong with that. Then on 8-11-14 they increased the Ph III trial size to 348 patients and gave shareholders the impression that it only increased 36 patients. Now when you read "about us", their Ph III trial is 348 patients, but the up to 72 psPDs that they have permission to recruit is no longer in that count. The trial didn't increase 36 patients, it increased by 108 patients. I'd rather they not use fussy math and have them give investors the real facts. It doesn't matter to me that they're using the real facts now. They need to use the real facts in their PRs. That's all I ask.